{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:16:08Z","timestamp":1790226968956,"version":"4.1.0"},"reference-count":73,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:p>In 2019, stride velocity 95th centile (SV95C) became the first wearable-derived digital clinical outcome assessment (COA) qualified by the European Medicines Agency (EMA) for use as a secondary endpoint in trials for Duchenne muscular dystrophy. SV95C was approved via the EMA\u2019s qualification pathway for novel methodologies for medicine development, which is a voluntary procedure for assessing the regulatory acceptability of innovative methods used in pharmaceutical research and development. SV95C is an objective, real-world digital ambulation measure of peak performance, representing the speed of the fastest strides taken by the wearer over a recording period of 180 hours. SV95C is correlated with traditional clinic-based assessments of motor function and has greater sensitivity to clinical change over 6 months than other wearable-derived stride variables, for example, median stride length or velocity. SV95C overcomes many limitations of episodic, clinic-based motor function testing, allowing the assessment of ambulation ability between clinic visits and under free-living conditions. Here we highlight considerations and challenges in developing SV95C using evidence generated by a high-performance wearable sensor. We also provide a commentary of the device\u2019s technical capabilities, which were a determining factor in the regulatory approval of SV95C. This article aims to provide insights into the methods employed, and the challenges faced, during the regulatory approval process for researchers developing new digital tools for patients with diseases that affect motor function.<\/jats:p>","DOI":"10.3233\/jnd-210743","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T13:00:36Z","timestamp":1640091636000},"page":"335-346","source":"Crossref","is-referenced-by-count":81,"title":["Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials"],"prefix":"10.1177","volume":"9","author":[{"given":"Laurent","family":"Servais","sequence":"first","affiliation":[{"name":"Division of Child Neurology, Centre de R\u00e9f\u00e9rences des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Li\u00e8ge and University of Li\u00e8ge, Li\u00e8ge, Belgium"},{"name":"Muscular Dystrophy UK Oxford Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Yen","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitea","family":"Guridi","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Lukawy","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vissi\u00e8re","sequence":"additional","affiliation":[{"name":"Sysnav SAS, Vernon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Strijbos","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"S5","key":"10.3233\/JND-210743_ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/dmcn.94_12887","article-title":"Role of motivation on performance of the 6-minute walk test in boys with Duchenne muscular dystrophy","volume":"57","author":"Alfano","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"12","key":"10.3233\/JND-210743_ref2","doi-asserted-by":"crossref","first-page":"e114273","DOI":"10.1371\/journal.pone.0114273","article-title":"Decreased variability of the 6-minute walk test by heart rate correction in patients with neuromuscular disease","volume":"9","author":"Prahm","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.3233\/JND-210743_ref3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/14656566.2020.1732350","article-title":"New and emerging pharmacotherapy for duchenne muscular dystrophy: A focus on synthetic therapeutics","volume":"21","author":"Grages","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.3233\/JND-210743_ref4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1545968311425908","article-title":"The promise of mHealth: Daily activity monitoring and outcome assessments by wearable sensors","volume":"25","author":"Dobkin","year":"2011","journal-title":"Neurorehabil Neural Repair"},{"issue":"3","key":"10.3233\/JND-210743_ref8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mus.25743","article-title":"Longitudinal community walking activity in Duchenne muscular dystrophy","volume":"57","author":"Fowler","year":"2018","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.3233\/JND-210743_ref9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.apmr.2004.10.012","article-title":"Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy","volume":"86","author":"McDonald","year":"2005","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"1","key":"10.3233\/JND-210743_ref10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cpt.966","article-title":"Wearable devices in clinical trials: Hype and hypothesis","volume":"104","author":"Izmailova","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.3233\/JND-210743_ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.60.2.127","article-title":"Evaluating neurological outcome measures: The bare essentials","volume":"60","author":"Hobart","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.3233\/JND-210743_ref12","first-page":"e5610","article-title":"Determining an appropriate outcome measure in neurosurgical research: Investigating meaningful, valid, and practical metrics","volume":"11","author":"Louie","year":"2019","journal-title":"Cureus"},{"key":"10.3233\/JND-210743_ref15","doi-asserted-by":"crossref","unstructured":"Lilien C, Gasnier E, Gidaro T, Seferian A, Grelet M, Vissi\u00e8re D, et al. Home-based monitor for gait and activity analysis. J Vis Exp. 2019(150).","DOI":"10.3791\/59668"},{"issue":"2","key":"10.3233\/JND-210743_ref17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000517411","article-title":"First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases","volume":"5","author":"Servais","year":"2021","journal-title":"Digital Biomarkers"},{"issue":"7","key":"10.3233\/JND-210743_ref18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nmd.2019.06.003","article-title":"European regulators\u2019 views on a wearable-derived performance measurement of Ambulation for Duchenne muscular dystrophy regulatory trials","volume":"29","author":"Haberkamp","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-210743_ref19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.gaitpost.2018.03.020","article-title":"Gait deviations in Duchenne muscular dystrophy\u2014Part 1","volume":"62","author":"Goudriaan","year":"2018","journal-title":"A systematic review. Gait & posture"},{"issue":"3","key":"10.3233\/JND-210743_ref20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.3233\/JND-210743_ref21","doi-asserted-by":"crossref","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","article-title":"Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study","volume":"13","author":"Chabanon","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.3233\/JND-210743_ref22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/acn3.51281","article-title":"Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study","volume":"8","author":"Annoussamy","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JND-210743_ref23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpeds.2018.02.073","article-title":"Learning and encouragement effects on six-minute walking test in children","volume":"198","author":"Morales Mestre","year":"2018","journal-title":"J Pediatr"},{"key":"10.3233\/JND-210743_ref24","doi-asserted-by":"crossref","unstructured":"Reilmann R, Schubert R. Chapter 18 -Motor outcome measures in Huntington disease clinical trials. In: Feigin AS, Anderson KE, editors. Handbook of Clinical Neurology. 144: Elsevier; 2017. pp. 209\u201325.","DOI":"10.1016\/B978-0-12-801893-4.00018-3"},{"issue":"1","key":"10.3233\/JND-210743_ref25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000477383","article-title":"The first frontier: Digital biomarkers for neurodegenerative disorders","volume":"1","author":"Dorsey","year":"2017","journal-title":"Digital Biomarkers"},{"issue":"4","key":"10.3233\/JND-210743_ref27","doi-asserted-by":"crossref","first-page":"e0121799","DOI":"10.1371\/journal.pone.0121799","article-title":"Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: An observational multicenter trial","volume":"10","author":"Seferian","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.3233\/JND-210743_ref28","doi-asserted-by":"crossref","first-page":"e0113999","DOI":"10.1371\/journal.pone.0113999","article-title":"Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: An observational multicenter trial","volume":"10","author":"Seferian","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.3233\/JND-210743_ref29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s00415-020-09800-9","article-title":"Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy","volume":"267","author":"Hogrel","year":"2020","journal-title":"J Neurol"},{"issue":"4","key":"10.3233\/JND-210743_ref30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"issue":"10101","key":"10.3233\/JND-210743_ref31","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.3233\/JND-210743_ref32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JND-210743_ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA approves eteplirsen for Duchenne muscular dystrophy: The next chapter in the eteplirsen saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther"},{"issue":"1","key":"10.3233\/JND-210743_ref35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2017.10.004","article-title":"A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy","volume":"28","author":"Goemans","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"24","key":"10.3233\/JND-210743_ref37","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production","volume":"90","author":"Charleston","year":"2146","journal-title":"Neurology"},{"issue":"15 Supplement","key":"10.3233\/JND-210743_ref38","first-page":"P1.6","article-title":"Effect of Ataluren on Age at Loss of Ambulation in Nonsense Mutation Duchenne Muscular Dystrophy: Observational Data from the STRIDE Registry (P1.6-067).","volume":"92","author":"Delage","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JND-210743_ref44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/nat.2018.0756","article-title":"A sequel to the eteplirsen saga: Eteplirsen is approved in the United States but was not approved in Europe","volume":"29","author":"Aartsma-Rus","year":"2018","journal-title":"Nucleic Acid Ther"},{"issue":"2","key":"10.3233\/JND-210743_ref45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00431-018-3272-1","article-title":"Injection site reactions after long-term subcutaneous delivery of drisapersen: A retrospective study","volume":"178","author":"Hilhorst","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.3233\/JND-210743_ref46","doi-asserted-by":"crossref","first-page":"e108205","DOI":"10.1371\/journal.pone.0108205","article-title":"Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes","volume":"9","author":"Pane","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"10.3233\/JND-210743_ref47","doi-asserted-by":"crossref","first-page":"e0164684","DOI":"10.1371\/journal.pone.0164684","article-title":"Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy","volume":"11","author":"Goemans","year":"2016","journal-title":"PLOS ONE"},{"issue":"4","key":"10.3233\/JND-210743_ref48","first-page":"587","article-title":"Early signs of gait deviation in Duchenne muscular dystrophy","volume":"47","author":"Doglio","year":"2011","journal-title":"Eur J Phys Rehabil Med"},{"issue":"5","key":"10.3233\/JND-210743_ref50","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.measurement.2012.01.015","article-title":"Characterization and calibration of MEMS inertial sensors for state and parameter estimation applications","volume":"45","author":"Aydemir","year":"2012","journal-title":"Measurement"},{"issue":"12","key":"10.3233\/JND-210743_ref52","doi-asserted-by":"crossref","first-page":"31314","DOI":"10.3390\/s151229858","article-title":"Physical Human Activity Recognition Using Wearable Sensors","volume":"15","author":"Attal","year":"2015","journal-title":"Sensors (Basel)"},{"key":"10.3233\/JND-210743_ref53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.gaitpost.2017.06.019","article-title":"A systematic review of gait analysis methods based on inertial sensors and adaptive algorithms","volume":"57","author":"Caldas","year":"2017","journal-title":"Gait Posture"},{"issue":"5","key":"10.3233\/JND-210743_ref54","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.3390\/s120506102","article-title":"Inertial sensor-based methods in walking speed estimation: A systematic review","volume":"12","author":"Yang","year":"2012","journal-title":"Sensors (Basel)"},{"key":"10.3233\/JND-210743_ref55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3389\/fpsyg.2017.00817","article-title":"Inertial sensors to assess gait quality in patients with neurological disorders: A systematic review of technical and analytical challenges","volume":"8","author":"Vienne","year":"2017","journal-title":"Front Psychol"},{"issue":"20","key":"10.3233\/JND-210743_ref56","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3390\/s19204491","article-title":"Robust stride detector from ankle-mounted inertial sensors for pedestrian navigation and activity recognition with machine learning approaches","volume":"19","author":"Beaufils","year":"2019","journal-title":"Sensors (Basel)"},{"issue":"12","key":"10.3233\/JND-210743_ref57","doi-asserted-by":"crossref","first-page":"23230","DOI":"10.3390\/s141223230","article-title":"Drift Removal for Improving the Accuracy of Gait Parameters Using Wearable Sensor Systems","volume":"14","author":"Takeda","year":"2014","journal-title":"Sensors"},{"issue":"24","key":"10.3233\/JND-210743_ref58","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1109\/JSEN.2016.2593011","article-title":"3D human gait reconstruction and monitoring using body-worn inertial sensors and kinematic modeling","volume":"16","author":"Ahmadi","year":"2016","journal-title":"IEEE Sens J"},{"issue":"9","key":"10.3233\/JND-210743_ref59","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/s16091455","article-title":"Drift reduction in pedestrian navigation system by exploiting motion constraints and magnetic field","volume":"16","author":"Ilyas","year":"2016","journal-title":"Sensors (Basel)"},{"key":"10.3233\/JND-210743_ref60","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4028\/www.scientific.net\/AMR.255-260.2077","article-title":"MEMS gyroscope null drift and compensation based on neural network","volume":"255","author":"Shiau","year":"2011","journal-title":"Advanced Materials Research"},{"issue":"6","key":"10.3233\/JND-210743_ref62","doi-asserted-by":"crossref","first-page":"e0156696","DOI":"10.1371\/journal.pone.0156696","article-title":"A movement monitor based on magneto-inertial sensors for non-ambulant patients with Duchenne muscular dystrophy: A pilot study in controlled environment","volume":"11","author":"Le Moing","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JND-210743_ref63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JND-160195","article-title":"Measuring habitual physical activity in neuromuscular disorders: A systematic review","volume":"4","author":"Jimenez-Moreno","year":"2017","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"10.3233\/JND-210743_ref64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0269215508098895","article-title":"Pedometer step counts in individuals with neurological conditions","volume":"23","author":"Elsworth","year":"2009","journal-title":"Clin Rehabil"},{"issue":"1","key":"10.3233\/JND-210743_ref65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13023-021-01956-5","article-title":"Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment","volume":"16","author":"Poleur","year":"2021","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.3233\/JND-210743_ref66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mus.23831","article-title":"Corticosteroids in Duchenne muscular dystrophy: Major variations in practice","volume":"48","author":"Griggs","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-210743_ref67","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.nmd.2019.06.246","article-title":"P.191Maximal stride velocity detects positive and negative changes over 6-month-time period in ambulant patients with Duchenne muscular dystrophy","volume":"29","author":"Servais","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.3233\/JND-210743_ref68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.otohns.2006.11.001","article-title":"Practical guides to understanding sample size and minimal clinically important difference (MCID)","volume":"136","author":"Neely","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.3233\/JND-210743_ref69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2014A world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-210743_ref70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12031-015-0700-9","article-title":"Drug development and challenges for neuromuscular clinical trials","volume":"58","author":"El Mouelhi","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JND-210743_ref71","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.5888\/pcd11.130262","article-title":"A feasibility study of wearable activity monitors for pre-adolescent school-age children","volume":"11","author":"Schaefer","year":"2014","journal-title":"Prev Chronic Dis"},{"issue":"10","key":"10.3233\/JND-210743_ref72","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.2196\/mhealth.7311","article-title":"Determinants for Sustained Use of an Activity Tracker: Observational Study","volume":"5","author":"Hermsen","year":"2017","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.3233\/JND-210743_ref73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fpubh.2016.00007","article-title":"Who Owns the Data? Open Data for Healthcare","volume":"4","author":"Kostkova","year":"2016","journal-title":"Front Public Health"},{"key":"10.3233\/JND-210743_ref75","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.nmd.2019.06.255","article-title":"Feasibility and baseline values of continuous movement measurement in patients with centronuclear myopathy by using ActiMyo","volume":"29","author":"Annoussamy","year":"2019","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.3233\/JND-210743_ref76","first-page":"120","article-title":"Prognostic value of the Six-Minute Walk Test in heart failure","volume":"86","author":"Rubim","year":"2006","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"10.3233\/JND-210743_ref77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.rmed.2006.06.017","article-title":"Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients","volume":"101","author":"Takigawa","year":"2007","journal-title":"Respir Med"},{"key":"10.3233\/JND-210743_ref78","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2147\/CIA.S144045","article-title":"Quality of life and physical activity in an older working-age population","volume":"12","author":"Puciato","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"5","key":"10.3233\/JND-210743_ref79","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000381734","article-title":"Does physical activity improve quality of life in cancer patients undergoing chemotherapy?","volume":"38","author":"Kripp","year":"2015","journal-title":"Oncol Res Treat"},{"key":"10.3233\/JND-210743_ref80","doi-asserted-by":"crossref","first-page":"9606420","DOI":"10.1155\/2020\/9606420","article-title":"The adverse impact of glaucoma on psychological function and daily physical activity","volume":"2020","author":"Huang","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.3233\/JND-210743_ref81","first-page":"3521271","article-title":"Validation of activity tracking procedures in elderly patients after operative treatment of proximal femur fractures","volume":"2018","author":"Schmal","year":"2018","journal-title":"Rehabil Res Pract"},{"issue":"6","key":"10.3233\/JND-210743_ref82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2014.17841","article-title":"Accuracy of Smartphone Applications and Wearable Devices for Tracking Physical Activity Data","volume":"313","author":"Case","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"10.3233\/JND-210743_ref83","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1249\/MSS.0000000000000289","article-title":"Age group comparability of raw accelerometer output from wrist- and hip-worn monitors","volume":"46","author":"Hildebrand","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"10.3233\/JND-210743_ref84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.maturitas.2018.03.016","article-title":"The validity and reliability of consumer-grade activity trackers in older, community-dwelling adults: A systematic review","volume":"112","author":"Straiton","year":"2018","journal-title":"Maturitas"},{"issue":"1","key":"10.3233\/JND-210743_ref85","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cts.12851","article-title":"Remote Digital Monitoring for Medical Product Development","volume":"14","author":"Izmailova","year":"2021","journal-title":"Clinical and Translational Science"},{"issue":"2","key":"10.3233\/JND-210743_ref86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00147","article-title":"Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials","author":"Cox","year":"2018","journal-title":"JCO Clinical Cancer Informatics"},{"issue":"1","key":"10.3233\/JND-210743_ref88","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000512513","article-title":"A roadmap to inform development, validation and approval of digital mobility outcomes: The Mobilise-D approach","volume":"4","author":"Rochester","year":"2020","journal-title":"Digital Biomarkers."},{"key":"10.3233\/JND-210743_ref89","first-page":"S108","article-title":"Towards high-resolution clinical digital biomarkers for Duchenne muscular dystrophy","volume":"29","author":"Ricotti","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-210743_ref90","first-page":"S109","article-title":"P","volume":"29","author":"Ricotti","year":"2019","journal-title":"205Daily life digital biomarkers for longitudinal monitoring of Duchenne muscular dystrophy with wearable sensors. Neuromuscular Disorders"},{"key":"10.3233\/JND-210743_ref91","doi-asserted-by":"crossref","first-page":"112582","DOI":"10.1016\/j.sna.2021.112582","article-title":"Development of electrical transduction based wearable tactile sensors for human vital signs monitor: Fundamentals, methodologies and applications","volume":"321","author":"Suresh Kumar","year":"2021","journal-title":"Sensors and Actuators A: Physical"},{"issue":"4","key":"10.3233\/JND-210743_ref92","doi-asserted-by":"crossref","first-page":"e10733","DOI":"10.2196\/10733","article-title":"Clinical applications of mobile health wearable-based sleep monitoring: Systematic review","volume":"8","author":"Guillodo","year":"2020","journal-title":"JMIR mHealth and uHealth"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-210743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:56Z","timestamp":1777506596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-210743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":73,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jnd-210743","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}